In April 2025, Kamau Therapeutics announced a study is a first-in-human, single-arm, open-label Phase I/II study of nula-cel ...

9 Briefly, the plan provides for the use of Mercuhydrin by intramuscular injection as the standard against which other drugs or the same drug by different routes of administration is compared.

But since then, other routes of administration have become available. One of these alternative triptan routes is ...

Finally, the rates of absorption and time to peak plasma concentrations are comparable to IV administration, and are generally superior to subcutaneous or intramuscular routes. The use of IN ...

independent of the route of administration. In this study on intravenous administration, no short-term problems with regard to efficacy or tolerability were observed when patients were switched ...